382
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Clinical and Epidemiological Characteristics of 30 Fatal Cases of Crimean-Congo Hemorrhagic Fever in Kabul, Afghanistan: A Retrospective Observational Study

ORCID Icon, ORCID Icon & ORCID Icon
Pages 3469-3476 | Received 01 Apr 2023, Accepted 30 May 2023, Published online: 02 Jun 2023

References

  • World Health Organization. Introduction to Crimean-Congo haemorrhagic fever; 2018. Available from: https://cdn.who.int/media/docs/default-source/documents/health-topics/crimean-congo-haemorrhaigc-fever/introduction-to-crimean-congo-haemorrhagic-fever.pdf?sfvrsn=14c8c199_2&download=true. Accessed May 31, 2023.
  • CDC. Crimean-Congo hemorrhagic fever; 2018. Available from: https://www.cdc.gov/vhf/crimean-congo/pdf/factsheet.pdf. Accessed May 31, 2023.
  • Aslam S, Latif MS, Daud M, et al. Crimean‑Congo hemorrhagic fever: risk factors and control measures for the infection abatement (Review). Biomed Rep. 2016;4:15–20. doi:10.3892/br.2015.545
  • Garrison AR, Alkhovsky V, Avšič-županc T, et al. ICTV virus taxonomy profile: nairoviridae. J Gen Virol. 2020;101(8):798–799. doi:10.1099/jgv.0.001485
  • Mostafavi E, Pourhossein B, Chinikar S. Clinical symptoms and laboratory findings supporting early diagnosis of Crimean-Congo Hemorrhagic fever in Iran. J Med Virol. 2014;86(7):1188–1192. doi:10.1002/jmv.23922
  • Sahak MN, Arifi F, Sayedzai SA. Descriptive epidemiology of Crimean-Congo Hemorrhagic Fever (CCHF) in Afghanistan: reported cases to National Surveillance System, 2016 –2018. Int J Infect Dis. 2019;88:135–140. doi:10.1016/j.ijid.2019.08.016
  • Ince Y, Yasa C, Metin M, et al. Crimean-Congo hemorrhagic fever infections reported by ProMED. Int J Infect Dis. 2014;26:44–46. doi:10.1016/j.ijid.2014.04.005
  • Karakecili F, Cikman A, Aydin M, Binay UD, Kesik OA, Ozcicek F. Evaluation of epidemiological, clinical, and laboratory characteristics and mortality rate of patients with Crimean-Congo hemorrhagic fever in the northeast region of Turkey. J Vector Borne Dis. 2019;55(September):215–221. doi:10.4103/0972-9062.249479
  • Gönen İ. Clinical and laboratory findings of patients with Crimean-Congo hemorrhagic fever in the emergency department at hospital admission. J Microbiol Infect Dis. 2011;1(1):1–4. doi:10.5799/ahinjs.02.2011.01.0001
  • Kouhpayeh H. An overview of complications and mortality of Crimean-Congo hemorrhagic fever. Int J Infect. 2019;6(2):6–10. doi:10.5812/iji.91707
  • Farooq H, Beveridge N, Fletcher T, et al. A systematic review on the incidence and mortality of Crimean-Congo Haemorrhagic Fever (CCHF) in Pakistan. Int J Infect Dis. 2021;101:250. doi:10.1016/j.ijid.2020.11.088
  • Kilinc C, Gückan R, Capraz M, et al. Examination of the specific clinical symptoms and laboratory findings of Crimean-Congo hemorrhagic fever. J Vector Borne Dis. 2016;53(June):162–167.
  • Bakir M, Engin A, Gozel MG, Elaldi N, Kilickap S, Cinar Z. A new perspective to determine the severity of cases with Crimean-Congo hemorrhagic fever. J Vector Borne Dis. 2012;49(June):105–110.
  • Kuehnert PA, Stefan CP, Badger CV, Ricks KM. Crimean-Congo Hemorrhagic Fever Virus (CCHFV): a silent but widespread threat. Curr Trop Med Rep. 2021;8:141–147. doi:10.1007/s40475-021-00235-4
  • Cevik MA, Erbay A, Bodur H, et al. Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality. Int J Infect Dis. 2008;12:374–379. doi:10.1016/j.ijid.2007.09.010
  • Ahmed A, Tanveer M, Saqlain M, Khan GM. Knowledge, perception and attitude about Crimean Congo Hemorrhagic Fever (CCHF) among medical and pharmacy students of Pakistan. BMC Infect Dis. 2018;18:1–10. doi:10.1186/s12879-017-2892-9
  • Shahhosseini N, Wong G, Babuadze G, et al. Crimean-Congo Hemorrhagic fever virus in Asia, Africa and Europe. Microorganisms. 2021;9(1907):1–24. doi:10.3390/microorganisms9091907
  • Mustafa ML, Ayazi E, Mohareb E, et al. Crimean-Congo hemorrhagic fever, Afghanistan, 2009. Emerg Infect Dis. 2011;17(10):3–4. doi:10.3201/eid1710.110061
  • Ministry of Public Health A. National Disease Surveillance & Response (NDSR) weekly epidemiological report; 2022. Available from: https://moph.gov.af/sites/default/files/2022-01/NDSRWER52-2021.pdf. Accessed May 31, 2023.
  • Ministry of Public Health A. National Disease Surveillance & Response (NDSR) weekly epidemiological report; 2023. Available from: https://moph.gov.af/sites/default/files/2022-12/NDSRWER47-2022.pdf. Accessed May 31, 2023.
  • World Health Organization. Crimean-Congo Haemorrhagic Fever (CCHF) outbreak toolbox; 2022. Available from: https://cdn.who.int/media/docs/default-source/outbreak-toolkit/final_cchf-outbreak-toolbox_20221011.pdf?sfvrsn=757e0181_1. Accessed May 31, 2023.
  • Qaderi S, Mardani M, Shah A, Shah J, Bazgir N. Crimean-Congo Hemorrhagic Fever (CCHF) in Afghanistan: a retrospective single center study. Int J Infect Dis. 2021;103:323–328. doi:10.1016/j.ijid.2020.11.208
  • Hatami H, Qaderi S, Omid AM, González AD, de Andrade SM. Investigation of Crimean‑Congo hemorrhagic fever in patients admitted in Antani Hospital, Kabul, Afghanistan, 2017–2018. Int J Prev Med. 2019;10(117):1–5. doi:10.4103/ijpvm.IJPVM_40_18
  • Al-abri SS, Hewson R, Al-kindi H, et al. Clinical and molecular epidemiology of Crimean-Congo hemorrhagic fever in Oman. PLoS Negl Trop Dis. 2019;19(April):1–15.
  • Mofleh J, Ahmad AZ. Crimean–Congo haemorrhagic fever outbreak investigation in the Western Region of Afghanistan in; 2012. Available from: https://www.emro.who.int/emhj-volume-18-2012/issue-5/article-17.html. Accessed May 31, 2023.
  • World Health Organization. Crimean-Congo haemorrhagic fever; 2022. Available from: https://www.who.int/news-room/fact-sheets/detail/crimean-congo-haemorrhagic-fever. Accessed May 31, 2023.
  • Thierry J, Belobo E, Kenmoe S, et al. Worldwide epidemiology of Crimean-Congo hemorrhagic fever virus in humans, ticks and other animal species, a systematic review and meta-analysis. PLoS Negl Trop Dis. 2021;(April):1–19.
  • Sharifi-mood B, Metanat M, Alavi-naini R. Prevalence of Crimean-Congo hemorrhagic fever among high risk human groups. Int J High Risk Behav Addict. 2014;3(1):5–8. doi:10.5812/ijhrba.11520
  • Farzinnia B, Saghafipour A, Telmadarraiy Z. Study of the epidemiological status of Crimean-Congo hemorrhagic fever disease in Qom Province, 2011, Iran. Qom Univ Med Sci J. 2013;7(4):2013.
  • Kavak N, Gürbüz Y. Factors affecting mortality in Crimean-Congo hemorrhagic fever. J Surg Med. 2019;3(6):428–432.
  • Ergonul O, Celikbas A, Baykam N, Eren S, Dokuzoguz B. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited. Eur Soc Clin Infect Dis. 2006;12(6):551–554.
  • Qaderi S, Hatami H, Omid AM, Sayad J. Vaginal bleeding as a sign of Crimean-Congo hemorrhagic fever infection: a case report. J Med Case Rep. 2022;16:1–4. doi:10.1186/s13256-021-03218-1
  • Niazi A-R, Jawad MJ, Amirnajad A, Durr PA, Williams DT. Crimean-Congo Hemorrhagic fever, Herat province, Afghanistan, 2017. Emerg Infect Dis. 2019;25(8):1596–1598. doi:10.3201/eid2508.181491
  • Bastug A, Kayaaslan B, Kazancioglu S, Aslaner H, But A. Crimean-Congo Hemorrhagic fever: prognostic factors and the association of Leukocyte counts with mortality. Jpn J Infect Dis. 2016;69(5):51–55. doi:10.7883/yoken.JJID.2014.566
  • Koksal I, Yilmaz G, Aksoy F, et al. The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey. J Clin Virol. 2010;47(1):65–68. doi:10.1016/j.jcv.2009.11.007
  • Arab-bafrani Z, Jabbari A, Hashemi MM, Arabzadeh AM, Gilanipour A, Mousavi E. Identification of the crucial parameters regarding the efficacy of ribavirin therapy in Crimean–Congo haemorrhagic fever (CCHF) patients: a systematic review and meta-analysis. J Antimicrobial Chemother. 2019;74(August):3432–3439. doi:10.1093/jac/dkz328